The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis
Publication
, Conference
Martel, C; Theroux, P; Labarthe, B; Rivard, J; Bonnefoy, A; Granger, CB; Armstrong, PW
Published in: CIRCULATION
October 16, 2007
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 16, 2007
Volume
116
Issue
16
Start / End Page
723 / 723
Location
Orlando, FL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
80th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Martel, C., Theroux, P., Labarthe, B., Rivard, J., Bonnefoy, A., Granger, C. B., & Armstrong, P. W. (2007). The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis. In CIRCULATION (Vol. 116, pp. 723–723). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
Martel, Catherine, Pierre Theroux, Benoit Labarthe, Jacinthe Rivard, Arnaud Bonnefoy, Christopher B. Granger, and Paul W. Armstrong. “The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis.” In CIRCULATION, 116:723–723. LIPPINCOTT WILLIAMS & WILKINS, 2007.
Martel C, Theroux P, Labarthe B, Rivard J, Bonnefoy A, Granger CB, et al. The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 723–723.
Martel, Catherine, et al. “The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis.” CIRCULATION, vol. 116, no. 16, LIPPINCOTT WILLIAMS & WILKINS, 2007, pp. 723–723.
Martel C, Theroux P, Labarthe B, Rivard J, Bonnefoy A, Granger CB, Armstrong PW. The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 723–723.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 16, 2007
Volume
116
Issue
16
Start / End Page
723 / 723
Location
Orlando, FL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
80th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology